GAIN THERAPEUTICS INC
GANX·36269B105·US·Common Stock·Healthcare - Biotechnology
GANX (GAIN THERAPEUTICS INC) is held by 33 institutional investors as of Q2 2026. Largest holders: MARSHALL WACE, LLP ($3.9M), DME Capital Management, LP ($1.1M), JONES FINANCIAL COMPANIES LLLP ($1.1M). Net institutional sentiment: Mixed.
33
Holders
(1 Elite)
$12.2M
Total Value
60% (30)
Consensus
18 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for GANX.
Top Holders
Checking access…
Showing 1-20 of 37
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer